Table 5.
Variable | OR (95% CI) | Adjusted ORa (95% CI) | Adjusted ORb (95% CI) |
Illness type (non-neurotic) | 2.8 (1.6–4.8) | 2.1 (1.1–4.1) | 2.2 (1.1–4.4) |
Combat arm | 1 | 1 | 1 |
Combat support arm | 0.5 (0.3–0.9) | 0.6 (0.3–1.4) | 0.7 (0.3–1.5) |
Combat service support | 0.4 (0.2–0.7) | 0.8 (0.4–1.8) | 0.9 (0.4–2.0) |
Gender (female) | 0.3 (0.2–0.7) | 0.4 (0.1–0.9) | 0.3 (0.1–0.9) |
Service length, 1–4 years | 1 | 1 | 1 |
Service length, 5–9 years | 0.1 (0.3–0.3) | 0.2 (0.1–0.5) | 0.1 (0.04–0.4) |
Service length, 10–15 years | 0.04 (0.01–0.1) | 0.1 (0.02–0.2) | 0.1 (0.02–0.2) |
Service length, >15 years | 0.03 (0.01–0.1) | 0.1 (0.02–0.2) | 0.1 (0.01–0.2) |
Previous community treatment | 0.6 (0.4–0.9) | 0.5 (0.3–1.0) | 0.5 (0.1–1.00) |
Rank (senior/warrant/officer) | 0.2 (0.1–0.3) | 0.5 (0.2–1.1) | 0.5 (0.2–1.1) |
Model 1 adjusted for the following confounders: illness type, combat arm, gender, service length, previous community treatment and rank.
Model 2 adjusted for Model 1 confounders plus type of treatment, where the variables were medication, group treatment, individual treatment, psychotherapy, cognitive behavioural therapy, eye movement desensitization and reprocessing and assessment only.